{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:21:17Z","timestamp":1778682077650,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T00:00:00Z","timestamp":1218240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s10557-008-6130-y","type":"journal-article","created":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T15:00:36Z","timestamp":1218207636000},"page":"437-442","source":"Crossref","is-referenced-by-count":12,"title":["A Single Intravenous sTNFR-Fc Administration at the Time of Reperfusion Limits Infarct Size\u2014Implications in Reperfusion Strategies in Man"],"prefix":"10.1007","volume":"22","author":[{"given":"Marie-Claire","family":"Toufektsian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Robbez-Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drissa","family":"Sanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Gabrielle","family":"Jouan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Ormezzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00ebl","family":"de Leiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,9]]},"reference":[{"key":"6130_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","volume":"53","author":"NG Frangogiannis","year":"2002","unstructured":"Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31\u201347.","journal-title":"Cardiovasc Res"},{"key":"6130_CR2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0003-4975(92)91021-Z","volume":"54","author":"NJ Jansen","year":"1992","unstructured":"Jansen NJ, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992;54:744\u20137.","journal-title":"Ann Thorac Surg"},{"key":"6130_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2796.1989.tb00090.x","volume":"225","author":"CP Maury","year":"1989","unstructured":"Maury CP, Teppo AM. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med 1989;225:333\u20136.","journal-title":"J Intern Med"},{"key":"6130_CR4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","volume":"93","author":"G Torre-Amione","year":"1996","unstructured":"Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704\u201311.","journal-title":"Circulation"},{"key":"6130_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0735-1097(96)00105-2","volume":"28","author":"J Gurevitch","year":"1996","unstructured":"Gurevitch J, Frolkis I, Yuhas Y, et al. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 1996;28:247\u201352.","journal-title":"J Am Coll Cardiol"},{"key":"6130_CR6","first-page":"419","volume":"146","author":"A Herskowitz","year":"1995","unstructured":"Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic\/reperfused myocardium. Am J Pathol 1995;146:419\u201328.","journal-title":"Am J Pathol"},{"key":"6130_CR7","doi-asserted-by":"crossref","first-page":"H3014","DOI":"10.1152\/ajpheart.00797.2007","volume":"293","author":"C Moro","year":"2007","unstructured":"Moro C, Jouan MG, Rakotovao A, et al. Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodelling. Am J Physiol Heart Circ Physiol 2007;293:H3014\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6130_CR8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00395-003-0431-x","volume":"99","author":"R Schulz","year":"2004","unstructured":"Schulz R, Aker S, Belosjorow S, Heusch G. TNFalpha in ischemia\/reperfusion injury and heart failure. Basic Res Cardiol 2004;99:8\u201311.","journal-title":"Basic Res Cardiol"},{"key":"6130_CR9","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0735-1097(97)00328-8","volume":"30","author":"J Gurevitch","year":"1997","unstructured":"Gurevitch J, Frolkis I, Yuhas Y, et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 1997;30:1554\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"6130_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0306-3623(98)00050-0","volume":"32","author":"M McVey","year":"1999","unstructured":"McVey M, Perrone MH, Clark KL. Does tumor necrosis factor-alpha (TNFalpha) contribute to myocardial reperfusion injury in anesthetized rats? Gen Pharmacol 1999;32:41\u20135.","journal-title":"Gen Pharmacol"},{"key":"6130_CR11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0002-8703(99)70375-3","volume":"137","author":"D Li","year":"1999","unstructured":"Li D, Zhao L, Liu M, Du X, Ding W, Zhang J, et al. Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J 1999;137:1145\u201352.","journal-title":"Am Heart J"},{"key":"6130_CR12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cardiores.2005.02.016","volume":"67","author":"D Gurantz","year":"2005","unstructured":"Gurantz D, Yndestad A, Halvorsen B, et al. Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling. Cardiovasc Res 2005;67:106\u201315.","journal-title":"Cardiovasc Res"},{"key":"6130_CR13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.healun.2004.06.021","volume":"23","author":"MF Berry","year":"2004","unstructured":"Berry MF, Woo YJ, Pirolli TJ, et al. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. J Heart Lung Transplant 2004;23:1061\u20138.","journal-title":"J Heart Lung Transplant"},{"key":"6130_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/B:MCBI.0000049149.03964.c9","volume":"266","author":"M Sugano","year":"2004","unstructured":"Sugano M, Hata T, Tsuchida K, et al. Local delivery of soluble TNFalpha receptor 1 gene reduces infarct size following ischemia\/reperfusion injury in rats. Mol Cell Biochem 2004;266:127\u201332.","journal-title":"Mol Cell Biochem"},{"key":"6130_CR15","doi-asserted-by":"crossref","first-page":"H340","DOI":"10.1152\/ajpheart.01210.2003","volume":"287","author":"C Berthonneche","year":"2004","unstructured":"Berthonneche C, Sulpice T, Boucher F, et al. New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats. Am J Physiol Heart Circ Physiol 2004;287:H340\u201350.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6130_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2004.03.012","volume":"37","author":"B Dawn","year":"2004","unstructured":"Dawn B, Guo Y, Rezazadeh A, Wang OL, Stein AB, Hunt G, et al. Tumor necrosis factor-alpha does not modulate ischemia\/reperfusion injury in na\u00efve myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 2004;37:51\u201361.","journal-title":"J Mol Cell Cardiol"},{"key":"6130_CR17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00395-004-0509-0","volume":"100","author":"F Labruto","year":"2005","unstructured":"Labruto F, Yang J, Vaage J, Valen G. Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia. Basic Res Cardiol 2005;100:198\u2013207.","journal-title":"Basic Res Cardiol"},{"key":"6130_CR18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.RES.0000255031.15793.86","volume":"100","author":"A Skyschally","year":"2007","unstructured":"Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, et al. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 2007;100:140\u20136.","journal-title":"Circ Res"},{"key":"6130_CR19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/jmcc.2002.1533","volume":"34","author":"S Lecour","year":"2002","unstructured":"Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 2002;34:509\u201318.","journal-title":"J Mol Cell Cardiol"},{"key":"6130_CR20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.yjmcc.2003.09.019","volume":"35","author":"M Tanno","year":"2003","unstructured":"Tanno M, Gorog DA, Bellahcene M, Cao X, Quinlan RA, Marber MS. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. J Mol Cell Cardiol 2003;35:1523\u20137.","journal-title":"J Mol Cell Cardiol"},{"key":"6130_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0163-7258(02)00176-6","volume":"94","author":"M Sack","year":"2002","unstructured":"Sack M. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol Ther 2002;94:123\u201335.","journal-title":"Pharmacol Ther"},{"key":"6130_CR22","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJM198211043071904","volume":"307","author":"MJ Stampfer","year":"1982","unstructured":"Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens CH. Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. N Engl J Med 1982;307:1180\u20132.","journal-title":"N Engl J Med"},{"key":"6130_CR23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0735-1097(97)00439-7","volume":"31","author":"GW Stone","year":"1998","unstructured":"Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary angioplasty in myocardial infarction stent pilot trial investigators. J Am Coll Cardiol 1998;31:23\u201330.","journal-title":"J Am Coll Cardiol"},{"key":"6130_CR24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","volume":"91","author":"DL Mann","year":"2002","unstructured":"Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91:988\u201398.","journal-title":"Circ Res"},{"key":"6130_CR25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00024382-200202000-00006","volume":"17","author":"BD Shames","year":"2002","unstructured":"Shames BD, Barton HH, Reznikov LL, et al. Ischemia alone is sufficient to induce TNFl-apha mRNA and peptide in the myocardium. Shock 2002;17:114\u20139.","journal-title":"Shock"},{"key":"6130_CR26","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1161\/01.CIR.99.25.3224","volume":"99","author":"A Deswal","year":"1999","unstructured":"Deswal A, Bozkurt B, Seta Y, et al. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 1999;99:3224\u20136.","journal-title":"Circulation"},{"key":"6130_CR27","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/01.CIR.97.14.1382","volume":"97","author":"B Bozkurt","year":"1998","unstructured":"Bozkurt B, Kribbs SB, Clubb FJ Jr, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998;97:1382\u201391.","journal-title":"Circulation"},{"key":"6130_CR28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/hc3401.093154","volume":"104","author":"N Sivasubramanian","year":"2001","unstructured":"Sivasubramanian N, Coker ML, Kurrelmeyer KM, et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001;104:826\u201331.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-008-6130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-008-6130-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-008-6130-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:28:03Z","timestamp":1559237283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-008-6130-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,9]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["6130"],"URL":"https:\/\/doi.org\/10.1007\/s10557-008-6130-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,9]]}}}